Skip to main content Back to Top
Advertisement

10/9/2024

Potassium Chloride in Large Volume for Injection

Products Affected - Description

    • Potassium chloride injection, Baxter, 20 mEq/L, 5% dextrose 14 count, NDC 00338-0683-04
    • Potassium chloride injection, Fresenius Kabi, 10 mEq/L, 0.9% sodium chloride 10 count, NDC 65219-0667-10
    • Potassium chloride injection, Fresenius Kabi, 20 mEq/L, 0.9% sodium chloride 10 count, NDC 65219-0669-10
    • Potassium chloride injection, ICU Medical, 20 mEq/L, 5% dextrose 12 count, NDC 00990-7905-09
    • Potassium chloride injection, Baxter, 20 mEq/L, 5% dextrose and lactated ringers 14 count, NDC 00338-0811-04
    • Potassium chloride injection, ICU Medical, 20 mEq/L, 5% dextrose and lactated ringers 12 count, NDC 00990-7111-09
    • Potassium chloride injection, Baxter, 10 mEq/L, 5% dextrose and 0.45% sodium chloride 14 count, NDC 00338-0669-04
    • Potassium chloride injection, Baxter, 20 mEq/L, 5% dextrose and 0.2% sodium chloride 14 count, NDC 00338-0663-04
    • Potassium chloride injection, Baxter, 20 mEq/L, 5% dextrose and 0.45% sodium chloride 14 count, NDC 00338-0671-04
    • Potassium chloride injection, Baxter, 20 mEq/L, 5% dextrose and 0.9% sodium chloride 14 count, NDC 00338-0803-04
    • Potassium chloride injection, Baxter, 30 mEq/L, 5% dextrose and 0.45% sodium chloride 14 count, NDC 00338-0673-04
    • Potassium chloride injection, Baxter, 40 mEq/L, 5% dextrose and 0.45% sodium chloride 14 count, NDC 00338-0675-04
    • Potassium chloride injection, Fresenius Kabi, 10 mEq/500 mL, 5% dextrose and 0.2% sodium chloride 20 count, NDC 65219-0151-75
    • Potassium chloride injection, Fresenius Kabi, 10 mEq/500 mL, 5% dextrose and 0.45% sodium chloride 20 count, NDC 65219-0150-75
    • Potassium chloride injection, Fresenius Kabi, 10 mEq/L, 5% dextrose and 0.45% sodium chloride 10 count, NDC 65219-0142-10
    • Potassium chloride injection, Fresenius Kabi, 20 mEq/L, 5% dextrose and 0.2% sodium chloride 10 count, NDC 65219-0153-10
    • Potassium chloride injection, Fresenius Kabi, 20 mEq/L, 5% dextrose and 0.45% sodium chloride 10 count, NDC 65219-0144-10
    • Potassium chloride injection, Fresenius Kabi, 20 mEq/L, 5% dextrose and 0.45% sodium chloride 10 count, NDC 63323-0683-10
    • Potassium chloride injection, Fresenius Kabi, 20 mEq/L, 5% dextrose and 0.9% sodium chloride 10 count, NDC 65219-0118-10
    • Potassium chloride injection, Fresenius Kabi, 30 mEq/L, 5% dextrose and 0.45% sodium chloride 10 count, NDC 65219-0146-10
    • Potassium chloride injection, Fresenius Kabi, 40 mEq/L, 5% dextrose and 0.45% sodium chloride 10 count, NDC 65219-0148-10
    • Potassium chloride injection, Fresenius Kabi, 40 mEq/L, 5% dextrose and 0.9% sodium chloride 10 count, NDC 65219-0119-10
    • Potassium chloride injection, ICU Medical, 10 mEq/500 mL, 5% dextrose and 0.45% sodium chloride 24 count, NDC 00990-7902-03
    • Potassium chloride injection, ICU Medical, 10 mEq/L, 5% dextrose and 0.45% sodium chloride 12 count, NDC 00990-7993-09
    • Potassium chloride injection, ICU Medical, 20 mEq/L, 5% dextrose and 0.225% sodium chloride 12 count, NDC 00990-7901-09
    • Potassium chloride injection, ICU Medical, 20 mEq/L, 5% dextrose and 0.45% sodium chloride 12 count, NDC 00990-7902-09
    • Potassium chloride injection, ICU Medical, 20 mEq/L, 5% dextrose and 0.9% sodium chloride 12 count, NDC 00990-7107-09
    • Potassium chloride injection, ICU Medical, 30 mEq/L, 5% dextrose and 0.45% sodium chloride 12 count, NDC 00990-7903-09
    • Potassium chloride injection, ICU Medical, 40 mEq/L, 5% dextrose and 0.45% sodium chloride 12 count, NDC 00990-7904-09
    • Potassium chloride injection, ICU Medical, 40 mEq/L, 5% dextrose and 0.9% sodium chloride 12 count, NDC 00990-7109-09
    • Potassium chloride injection, Baxter, 20 mEq/L, 0.45% sodium chloride 14 count, NDC 00338-0704-34
    • Potassium chloride injection, Baxter, 20 mEq/L, 0.9% sodium chloride 14 count, NDC 00338-0691-04
    • Potassium chloride injection, Baxter, 40 mEq/L, 0.9% sodium chloride 14 count, NDC 00338-0695-04
    • Potassium chloride injection, Fresenius Kabi, 20 mEq/L, 0.9% sodium chloride 10 count, NDC 65219-0686-10
    • Potassium chloride injection, Fresenius Kabi, 40 mEq/L, 0.9% sodium chloride 10 count, NDC 65219-0688-10
    • Potassium chloride injection, ICU Medical, 20 mEq/L, 0.45% sodium chloride 12 count, NDC 00990-9257-39
    • Potassium chloride injection, ICU Medical, 20 mEq/L, 0.9% sodium chloride 12 count, NDC 00990-7115-09
    • Potassium chloride injection, ICU Medical, 40 mEq/L, 0.9% sodium chloride 12 count, NDC 00990-7116-09
    • Potassium chloride injection, Baxter, 40 mEq/100 mL, sterile water Viaflex container, 24 count, NDC 00338-0703-48

Reason for the Shortage

    • Baxter has sustained damage to their North Cove plant that supplies large volume fluids.

Available Products

    • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • All marketed presentations are on allocation.

Alternative Agents & Management

    • See ASHP Suggestions for Management and Conservation during Fluid Shortages at https://www.ashp.org/drug-shortages/shortage-resources/publications/fluid-shortages-suggestions-for-management-and-conservation

Updated

Created October 9, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.
ADVERTISEMENT